Loading...

1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors

ePostersLive by SciGen Technologies S.A. All rights reserved.

SOHO 2026 Annual Meeting

September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas

Posters by Title

Showing 1,267 results.

Thumbnail for Daratumumab-Based Treatment Strategies with Daratumumab-Lenalidomide Maintenance vs Lenalidomide Maintenance in Transplant Eligible NDMM: A Systematic Review and Meta-Analysis

MM - 1453

Daratumumab-Based Treatment Strategies with Daratumumab-Lenalidomide Maintenance vs Lenalidomide Maintenance in Transplant Eligible NDMM: A Systematic Review and Meta-Analysis

Devesh Amin

Poster Presenter: Devesh Amin

Thumbnail for Daybreak CLL-201: A Study of Bexobrutideg (NX-5948), a Bruton Tyrosine Kinase (BTK) Degrader, in Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Previously Treated With a Covalent BTK Inhibitor, a Noncovalent BTK Inhibitor, and a BCL2 Inhibitor

CLL - 429

Daybreak CLL-201: A Study of Bexobrutideg (NX-5948), a Bruton Tyrosine Kinase (BTK) Degrader, in Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Previously Treated With a Covalent BTK Inhibitor, a Noncovalent BTK Inhibitor, and a BCL2 Inhibitor

Michael Tees

Poster Presenter: Michael Tees

$Thumbnail for DAYBreak CLL-306: A Phase 3 Randomized Open-Label Trial of the Novel Bruton Tyrosine Kinase Degrader Bexobrutideg (NX-5948) vs Pirtobrutinib in Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma$

CLL - 432

DAYBreak CLL-306: A Phase 3 Randomized Open-Label Trial of the Novel Bruton Tyrosine Kinase Degrader Bexobrutideg (NX-5948) vs Pirtobrutinib in Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma

Megan Wang

Poster Presenter: Megan Wang

Thumbnail for Declining but Unequal: Trends and Sociodemographic Disparities in Acute Myeloid Leukemia Mortality in the United States, 2018-2024

AML - 402

Declining but Unequal: Trends and Sociodemographic Disparities in Acute Myeloid Leukemia Mortality in the United States, 2018-2024

Priscilla Kabutey

Poster Presenter: Priscilla Kabutey

Thumbnail for Declining Population-Level Infection-Attributed Mortality in Chronic Lymphocytic Leukemia in the United States, 1999-2020: A CDC WONDER Analysis

CLL - 370

Declining Population-Level Infection-Attributed Mortality in Chronic Lymphocytic Leukemia in the United States, 1999-2020: A CDC WONDER Analysis

Anas Mardini

Poster Presenter: Anas Mardini

Thumbnail for Deconvolution of Peripheral Blood Transcriptomes to Evaluate Immune Profiles Associated With Measurable Residual Disease in Pediatric Acute Lymphoblastic Leukemia: A Machine Learning-Driven Study

ALL - 486

Deconvolution of Peripheral Blood Transcriptomes to Evaluate Immune Profiles Associated With Measurable Residual Disease in Pediatric Acute Lymphoblastic Leukemia: A Machine Learning-Driven Study

Fatima Aslam

Poster Presenter: Fatima Aslam

Thumbnail for Deep molecular response duration predicts treatment-free remission in CML rescued after resistance, warning or major molecular response

CML - 310

Deep molecular response duration predicts treatment-free remission in CML rescued after resistance, warning or major molecular response

Delphine Rea

Poster Presenter: Delphine Rea

Thumbnail for Deep Remission, Delayed Immunity: Prospective Characterization of Normal B-Cell Reconstitution After Venetoclax Based Therapy in CLL and its Implications for Vaccination.

CLL - 880

Deep Remission, Delayed Immunity: Prospective Characterization of Normal B-Cell Reconstitution After Venetoclax Based Therapy in CLL and its Implications for Vaccination.

Chantal Saberian

Poster Presenter: Chantal Saberian

Thumbnail for Defining Clinically Meaningful Progression Risk Across the Spectrum of Monoclonal B-Cell Lymphocytosis: A Bayesian Rate-Based Synthesis

IBCL - 005

Defining Clinically Meaningful Progression Risk Across the Spectrum of Monoclonal B-Cell Lymphocytosis: A Bayesian Rate-Based Synthesis

Adarsh Vardhan Tangella

Poster Presenter: Adarsh Vardhan Tangella

This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.